US 9975937
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted A61KA61K38/00A61K38/1793
Quick answer
US patent 9975937 (Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia) held by THE UNITED SSTATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED SSTATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K38/1793, A61K38/2086, A61K45/06